Market Currents
Optimer Pharmaceuticals, Inc. (OPTR): Q4 EPS of $0.02 may not be comparable to consensus of by...
-
Wednesday, February 27, 8:28 AM ETOptimer Pharmaceuticals, Inc. (OPTR): Q4 EPS of $0.02 may not be comparable to consensus of by -$0.38. Gross product sales of $21.3M. Shares +11.5% premarket. (PR)
Other date
Latest Earnings Articles
